Reversion-inducing cysteine-rich protein with Kazal motifs interferes with epidermal growth factor receptor signaling

S Kitajima1, T Miki, Y Takegami

  • 1Division of Oncology and Molecular Biology, Cancer Research Institute, Kanazawa University, Kanazawa, Ishikawa, Japan.

Oncogene
|October 5, 2010
PubMed

Insights

The reversion-inducing cysteine-rich protein with Kazal motifs (RECK) gene, initially known to inhibit RAS signaling, was found to modulate epidermal growth factor receptor (EGFR) signaling, impacting cellular senescence and proliferation.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Cancer Research

Background:

  • The reversion-inducing cysteine-rich protein with Kazal motifs (RECK) gene was identified as a RAS signaling antagonist.
  • The precise mechanism of RECK's action remained unclear.

Purpose of the Study:

  • To elucidate the functional role of RECK in cellular processes.
  • To investigate RECK's impact on RAS and EGFR signaling pathways.

Main Methods:

  • Germline knockout and short hairpin RNA (shRNA)-mediated depletion of RECK in mouse embryonic fibroblasts (MEFs).
  • 3T3 cell-cultivation protocol.
  • Analysis of cell proliferation, senescence markers (p19Arf, p53, p21Cdkn1a), and signaling pathway activity (RAS, AKT, ERK, EGFR).

Main Results:

  • RECK knockout led to accelerated proliferation and early senescence escape, with downregulated p19Arf, Trp53, and p21Cdkn1a.
  • RECK depletion induced irreversible growth arrest and senescence, with transient AKT and ERK activation, followed by negative feedback on RAS signaling.
  • RECK depletion transiently upregulated EGFR activity in MEFs, while RECK overexpression downregulated it in colon cancer cells.

Conclusions:

  • RECK plays a dual role in regulating cell proliferation and senescence.
  • RECK acts as a novel modulator of epidermal growth factor receptor (EGFR) signaling.
  • Understanding RECK's function provides insights into cancer development and potential therapeutic strategies.

Related Concept Videos

Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal01:22

Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal

Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.
Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
Enzyme-linked Receptors01:00

Enzyme-linked Receptors

Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...